The founder of a $50,000 startup that lets developers and researchers track and analyze medical records has been named as one of the top entrepreneurs in the world by Forbes.
Seth Miller, whose company, BioMedInfo, raised $15 million from the Massachusetts Institute of Technology in January, announced the honor in a post on LinkedIn on Monday.
“My goal is to empower everyone to be their own genomics and health data expert,” he wrote.
“In this way, everyone can get the information they need to make informed decisions, and build the data analytics tools they need, with the ease of the modern world.”
BioMedInfo uses a cloud-based platform to analyze health data from health-care providers.
Its software is designed to be as user-friendly as possible, and has been adopted by more than 20 medical research labs.
Miller said he and his cofounder, Eric Tarnopolsky, are planning to raise money for the company as it continues to grow.
“We were lucky enough to be in a position to raise the right funding to get BioMed Info up and running,” Miller said.
“The platform we’re building is designed for the most data-driven individuals and teams to access it, with a single, simple, and intuitive interface.”
BioMeInfo is now available for use by people with a medical condition or who want to work with researchers to develop new ways to analyze data.
The company says that users can track their health with their biometric data, as well as monitor how they are doing with their medications and their health-related issues.
Miller is also the founder of bioinformatics, a company that allows researchers to visualize medical records from other people and groups.
The BioMedinfo team has raised more than $3 million in seed funding, including $1 million from Founders Fund, and another $1.5 million from a small startup accelerator, according to the company’s website.
In March, the company added a new service that allows users to track their own biometric health data.
Miller said that BioMed info is not designed to make money for itself.
He said that the company hopes to raise $1 billion to $2 billion in a series of rounds.
“I think we’re at a point where we’re starting to feel comfortable enough to start building our company, and the investors are interested in making sure we can do this with their funding,” he said.